Smith-Lemli-Opitz syndrome (SLOS), desmosterolosis and lathosterolosis are human syndromes caused by defects in the final stages of cholesterol biosynthesis. Many of the developmental malformations in these syndromes occur in tissues and structures whose embryonic patterning depends on signaling by the Hedgehog (Hh) family of secreted proteins. Here we report that response to the Hh signal is compromised in mutant cells from mouse models of SLOS and lathosterolosis and in normal cells pharmacologically depleted of sterols. We show that decreasing levels of cellular sterols correlate with diminishing responsiveness to the Hh signal. This diminished response occurs at sterol levels sufficient for normal autoprocessing of Hh protein, which requires cholesterol as cofactor and covalent adduct. We further find that sterol depletion affects the activity of Smoothened (Smo), an essential component of the Hh signal transduction apparatus.
The role of cholesterol in Hh protein biogenesis suggested that impaired Hh autoprocessing might underlie some of the developmental abnormalities in SLOS ( Fig. 1 and Table 1 ; ref. 1 ). An additional role for cholesterol in Hh signal response was suggested by the observation that cyclopamine and jervine, teratogenic plant alkaloids that block Hh signaling, also inhibit cholesterol transport and synthesis 2, 3 . But cyclopamine has since been shown to specifically inhibit Hh signaling by binding to a pathway component 4 , and the doses of these alkaloids required to inhibit Hh signaling are lower than those required to block cholesterol transport (ref. 5 and M.K.C., unpublished data).
To determine how cholesterol may affect Hh signaling in embryonic development, we exposed chick embryos to cyclodextrin, a cyclic oligosaccharide that forms non-covalent complexes with sterols 6 and can be used to extract and deplete cholesterol from living cells 7 . Cyclodextrin treatment caused variable loss of the frontonasal process and other midline structures (Fig. 2a) , and the spectrum of facial defects was similar to that resulting from exposure to the Hh-pathway antagonist jervine 3 . The most severely affected embryos developed a proboscis-like structure that phenocopies the nasal rudiments of mouse embryos that are homozygous with respect to mutations in the gene Sonic hedgehog (Shh; ref. 8).
Fig. 1 Cholesterol biosynthesis and
Hh pathway. a, Autosomal recessive disorders with multiple developmental anomalies are associated with three different enzymatic defects (represented by solid colored lines) in the final steps of the cholesterol biosynthesis pathway. SLOS results from defects in DHCR7 (red line), lathosterolosis from defects in SC5D (green line) and desmosterolosis from defects in 3-β-hydroxysterol-∆ 24 -reductase (yellow line). Steps in sterol synthesis not shown are indicated by multiple arrows. b, After cleavage of the signal sequence (black box), the Hh precursor undergoes an internal cleavage reaction mediated by sequences in the C-terminal autoprocessing domain (white box). Cholesterol participates in the reaction and remains esterified to the newly formed C terminus of the signaling domain (shaded box). Fully processed, secreted Hh proteins (designated HhNp, p for processed) also receive an N-terminal palmitoyl group in a reaction requiring the acyltransferase Skinny hedgehog 30 We further investigated Shh signaling in embryonic tissues by exposing chick neural-plate explants to recombinant Shh protein (ShhN, 30 nM) in the presence of cyclodextrin (Fig. 2b ). The response to this level of ShhN protein was uniform production of HNF3β (hepatocyte nuclear factor 3β or forkhead box A2; ref. 3) , an indicator of floor plate fate. This high-threshold response was blocked in the presence of 400 µM cyclodextrin and replaced by nearly uniform expression of ISL1, an intermediate-threshold response indicative of motor-neuron fate. At 200 µM cyclodextrin, both HNF3β and ISL1 were expressed, suggesting that lower levels of cyclodextrin were less inhibitory. As active ShhN protein was exogenously supplied, this dose-dependent inhibition suggests that sterol deficits affect response to the Hh signal. Furthermore, this effect seemed to be specific, as treatment with 400 µM cyclodextrin alone did not inhibit BMP-induced migration of neural-crest cells 9 (Fig. 2c) . Hh protein biogenesis involves internal cleavage and covalent addition of cholesterol through an autoprocessing reaction 1 . Cyclodextrin treatment of cultured cells has previously been reported to interfere with Shh autoprocessing 10 , an effect distinct from inhibition of response that we observed. To further investigate whether signal production or signal response is the prevailing inhibitory mechanism in cholesterol synthesis disorders, we established embryonic fibroblast cell lines from mouse models of SLOS 11 and lathosterolosis and examined Shh signal biogenesis and response in parallel under identical culture conditions. Shh protein was efficiently processed in mouse embryonic fibroblasts (MEFs) lacking 7-dehydrocholesterol reductase (Dhcr7) or lathosterol 5-desaturase (Sc5d) enzymes (models of SLOS and lathosterolosis, respectively; see Fig. 1b) , with no observable effect of transient cyclodextrin treatment or growth in lipid-depleted culture medium (Fig. 3a) . All of the processed Nterminal product (ShhNp) from mutant cultures was cell-associated and had an electrophoretic mobility suggestive of sterol modification (Fig. 3a) . The autoprocessing reaction probably proceeds to completion because cholesterol levels are only reduced by roughly 50% under the conditions used for depletion (Fig. 3b ) and because 7-dehydrocholesterol and lathosterol both participate efficiently as sterol adducts in the Shh processing reaction 3 . Likewise, cholesterol levels are reduced but never absent in the serum of individuals with SLOS 12 .
In contrast with their normal Shh autoprocessing, MEFs with mutations in Dhcr7 and Sc5d had clear deficiencies in their ability to respond to Shh signal when transiently treated with cyclodextrin and grown in lipid-depleted culture medium (Fig. 3b) . These results indicate that signal response is more sensitive than is signal biogenesis to perturbations of cholesterol homeostasis. Cells heterozygous with respect to the mutations in Dhcr7 and Sc5d maintained a normal response to ShhNp stimulation under all growth conditions (Fig. 3b) , presumably because there was sufficient synthetic activity from the functional allele. In these experiments, the initial transient cyclodextrin treatment is needed to reduce sterol levels to below 40 µg mg -1 protein to affect pathway response (Fig. 3b) .
To further investigate Hh signal response in other cultured cells, we tested the ability of pharmacological interventions to mimic the effects of genetic defects in sterol biosynthesis. Continuous treatment with 500 µM cyclodextrin produced about 50% inhibition of Shh signal response in NIH3T3 cells, and 2 mM cyclodextrin produced nearly complete inhibition (Fig. 4a) (Fig. 4b) . ShhNp response was also not affected by continuous exposure to compactin, an inhibitor of 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG CoA) reductase that blocks sterol synthesis 13 . The combination of transient cyclodextrin treatment with continuous compactin exposure, however, blocked Shh signal response (Fig. 4b) . These data suggest that compactin treatment, when combined with transient cyclodextrin treatment, can mimic a genetic defect in sterol biosynthesis to inhibit Shh signal response. The Shh autoprocessing reaction was not affected by these experimental conditions (data not shown).
Cyclodextrins form complexes with hydrophobic compounds including proteins and phospholipids in addition to sterols 6 . But the effect of cyclodextrin treatment is probably due to sterol depletion, as transient cyclodextrin treatment only inhibited pathway activity in the presence of sterol biosynthetic mutations or of a statin, and no measurable recovery from the impact of deficits in molecules other than sterols was achieved during prolonged incubation after transient cyclodextrin treatment (Fig. 4c) . Furthermore, other sterol-specific perturbations, such as treatment with nystatin or filipin 14 , also blocked the response of cells to ShhNp protein (data not shown), and the degree of pathway inhibition in sterol biosynthetic mutant and statin-treated fibroblasts correlated inversely with total sterol levels (Fig. 4d ). An inhibitory role for 7-dehydrocholesterol, lathosterol and other cholesterol precursors that accumulate in the Dhcr7 and Sc5d mutant cells seems improbable because synthesis of such precursors in statin-treated wild-type cells is blocked. Indeed, the correlation between responsiveness and overall sterol content (Fig. 4d) suggests that these precursors may contribute to pathway response, although their effectiveness relative to that of cholesterol is unknown.
The ability to pharmacologically mimic sterol biosynthetic defects affords an opportunity to identify the Hh pathway component most directly affected by sterol perturbations. Patched (Fig. 3b) MEFs were determined by gas chromatography-mass spectrometry analysis of extracted lipids and plotted against the relative Shh pathway activity. Bars represent one standard error (quadruplicate wells).
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Gli family of transcription factors (Fig. 1b) . We examined the ability of sterol perturbations to affect the constitutive Hh pathway activity in fibroblasts derived from Ptch -/-embryos 15, 16 and found a dose-dependent reduction by transient treatment with increasing concentrations of cyclodextrin in combination with compactin (Fig. 5a) . Therefore, sterol depletion can block pathway activity independently of Ptch action and may act at a point in the pathway downstream of Ptch. We next examined the effects of depleting sterols in NIH3T3 cells stably transfected to express wild-type or oncogenic, activated Smo (ref. 16; SmoA1; W539L). We found that sterol depletion could completely block the modest level of pathway activation produced by overexpression of Smo (Fig. 5b) , but that it scarcely affected pathway activation by SmoA1 (Fig. 5c) . The susceptibility of wild-type Smo but resistance of a mutant activated form to sterol depletion suggests that Smo may be the site of sterol action. Consistent with this conclusion, sterol deprivation did not affect the activation of the pathway due to expression of Gli1, which acts downstream of Smo (data not shown). The retention of normal Hh pathway activity in cells expressing activated Smo indicates that pathway components downstream of Smo function normally under conditions of sterol depletion.
Previous work has suggested that Smo activity is governed by a balance between active and inactive conformations 16 . The resistance to cholesterol deprivation of activated Smo suggests that Smo conformation may be the target of cholesterol deprivation. This effect could be mediated either through direct interaction of cholesterol with Smo or through an impact on membrane properties, as reported for the function of other seven-transmembrane-domain proteins, such as the oxytocin or the brain cholecystokinin receptors 17 . One possibility is that sterol depletion could affect a lipid microdomain or raft-mediated process 18 required for Smo activity, although we did not observe a change in Smo fractionation with respect to detergent-resistant membranes on sterol depletion (data not shown). Alternatively, the effects of sterol depletion on Smo activity might be indirectly mediated through an as yet uncharacterized interacting component.
Sterol depletion has been previously reported to affect Shh autoprocessing 10 . This depletion was probably somewhat more severe than that produced by our experimental manipulations. Furthermore, we found that Hh signal response is more sensitive than Hh autoprocessing to inhibition by mutational or pharmacological sterol depletion. We therefore conclude that inhibition of response to Hh protein is a more probable cause of the malformations associated with cholesterol biosynthetic disorders than is inhibition of Hh autoprocessing. Other processes might also be affected by defects in distal cholesterol biosynthesis, as not all of the malformations are necessarily accounted for by impaired Hh signaling. Nevertheless, our findings help explain many developmental malformations associated with a relatively common genetic disorder, SLOS, whose incidence among European Caucasians is 1 in 22,000 (ref. 19) . Our findings may also be relevant to other etiologies of abnormal human development, as holoprosencephaly is reported to occur at a frequency of 1 in 250 among aborted fetuses 20 . The surprising connection between cholesterol synthesis and Hh signal response reported here suggests that signaling pathways involved in developmental patterning must be considered as potential targets of any seemingly simple metabolic defect associated with developmental malformations.
Methods
Chick embryos. We applied methyl-β-cyclodextrin (200 µl of a 10% w/v solution in L-15 medium (Sigma and Life Technologies)) to windowed, fertile chick eggs (White Leghorn) after 15 h of incubation. For an average egg volume of 50 ml, the final concentration of cyclodextrin was 375 µM. After 4 d of further incubation, we processed the embryos for scanning electron microscopy. We dissected the neural plate and epidermal ectoderm from stage 9-10 chick embryos, cultured them in collagen and induced them with purified ShhN 21 as described 3 . We added methyl-β-cyclodextrin to the chick explant cultures 4 h after induction with ShhN was initiated.
Analysis of Shh protein biogenesis.
We plated MEFs in a 10-cm 2 dish (Falcon) and transfected them (Fugene 6, Roche) with a full length Shh expression construct (pRK5-Shh, 5µg) when the cells were roughly 75% confluent. The next day, we changed the culture medium (Dulbecco's modified Eagle medium with 10% fetal bovine serum) to contain either 0.5% fetal bovine serum, 0.5% lipid-depleted serum or lipid-depleted serum after a 30-min treatment with 3.8 mM methyl-β-cyclodextrin (Sigma). After an additional 24 h in culture, we lysed the MEFs in RIPA buffer (50 mM TrisCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 1 mM EDTA, 1 µg ml -1 leupeptin, 1 µg ml aprotinin -1 , 0.2 mM phenylmethylsulfonyl fluoride), immunoprecipitated Shh protein from the cell lysates with a monoclonal antibody that recognizes the N-terminal signaling domain (5E1, Developmental Studies Hybridoma Bank) and immunoblotted them with a polyclonal antibody preparation (JH134).
Shh signaling assays. We carried out Shh signaling assays as described 16 in primary fibroblasts lacking functional Dhcr7, Sc5d or Ptch and in NIH3T3 fibroblasts. Dhcr7 -/-and Dhcr7 +/-MEFs were generated from embryonic day-9 mutant mice and Sc5d -/-and Sc5d +/-MEFs from embryonic day-14.5 mutant mice. We generated a reporter construct with firefly luciferase and Gli (pGL3-8×Gli-luciferase) by cloning eight tandem Gli-binding sites and a lens crystallin promoter from the 8×Gli-BS Luc construct 22 into the pGL3-Basic vector (Promega). We determined relative Hh pathway activity in Dhcr7 -/-, Dhcr7 +/-, Sc5d -/-and Sc5d +/-MEFs from the expression of transiently transfected pGL3-8×Gli-luciferase and control Renilla luciferase (pRL-SV40; Promega) vectors. In Ptch -/-MEFs, we normalized β-galactosidase activity expressed under the control of the Ptch promoter for protein levels to determine relative Hh pathway activity. In the NIH3T3 cell clone Shh-LIGHT Z3, we normalized 8×Gli-BS luciferase activity for β-galactosidase activity from stably transfected vectors (8×Gli-BS Luc 22 and pIZ-lacZ). We established clonal sublines of Shh-LIGHT Z3 by cotransfecting either Smo tagged with Myc epitope or SmoA1 with vector encoding G418 resistance (pGT; Invivogen). All transfections were done with Fugene 6. We carried out cyclodextrin treatments for 30 min with methyl-β-cyclodextrin (Sigma) dissolved in Dulbecco's modified Eagle medium, preceded and followed by two washes with phosphate-buffered saline. Fetal bovine serum was depleted of lipids as described 23 . We purchased compactin as an active sodium salt form of mevastatin (Biomol) and dissolved it in dimethylsulfoxide.
Sterol analysis. We extracted neutral sterols and analyzed them as described 24 from replicate wells of MEFs cultured in parallel with those used for Hh signaling assays.
